{"name":"STAAR Surgical Company","slug":"staar","ticker":"STAA","exchange":"NASDAQ","domain":"staar.com","description":"STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in ","hq":"Lake Forest, CA","founded":0,"employees":"921","ceo":"Tom Frinzi","sector":"Ophthalmology — Medical Devices","stockPrice":32.65,"stockChange":3.25,"stockChangePercent":11.05,"marketCap":"$1.6B","metrics":{"revenue":239442000,"revenueGrowth":18.1,"grossMargin":76.2,"rdSpend":40055000,"netIncome":-80448000,"cash":187536000,"dividendYield":0,"peRatio":35.5,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Visian Toric Implantable Collamer Lens patent cliff ($0.0B at risk)","drug":"Visian Toric Implantable Collamer Lens","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"STAAR Surgical Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"STAAR Surgical reported fourth quarter and full year 2023 financial results, with revenue of $44.4 million and a net loss of $13.4 million.","drugName":"","sentiment":"neutral"},{"date":"2023-09-26","type":"deal","headline":"STAAR Surgical Announces Collaboration with Alcon to Develop and Commercialize New Ophthalmic Products","summary":"STAAR Surgical announced a collaboration with Alcon to develop and commercialize new ophthalmic products, expanding the company's product portfolio.","drugName":"","sentiment":"positive"},{"date":"2023-05-02","type":"regulatory","headline":"STAAR Surgical Receives FDA Clearance for the Visian Toric Implantable Collamer Lens","summary":"STAAR Surgical received FDA clearance for the Visian Toric Implantable Collamer Lens, expanding the company's product offerings for the treatment of astigmatism.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQMXV4bzFnbFl3Z0RzREdZYkVVTTl5dU5xTWtJWmNoaVBsalF0dDYweUtsOVB4RVJDQVhoUm10Mks5YkFiZ3ZSWV92Tm5LRmI0ZlUzSVBKc3NDaVpFLS1CZ3dGSkNwN1VZRlRRTHBuNGdtNkRJSk9DcEVIODZJYWFIeVdqbTNBcC03R0NiWm1WR0hZTUQyTUliTUpMaHBGbEhPVFRNVHp5bG1CQ09QX3hmUVl3RlhNZHZ5Q3c?oc=5","date":"2026-03-25","type":"pipeline","source":"Seeking Alpha","summary":"STAAR Surgical: Despite Promises Of Improvement, Investors Should Stay Cautious (STAA) - Seeking Alpha","headline":"STAAR Surgical: Despite Promises Of Improvement, Investors Should Stay Cautious (STAA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOR1hxdTlDMHhuQkd2TzhYaEhkZk8tdFhhT19UVjJmWmxCWV85RElmR1RXUW9ZTEJ1TzQ5YXVjMFRDaXk0M2h6RzNKeV9ZTElxek5WYjFNRWEtTEdJUkVzQmpMRFVRamd3SHVRTnhVTWhuWUtHdElja2g0Mk5tSFJkMFktM3lVcVQ2OFZYVlg3NWwxSWRJMXdaMVFKakkyVjdIal9BSEpIUnZlSFFUeF9mMzBZZFRqRGts?oc=5","date":"2026-03-04","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Wednesday's Pre-Market Session - 20/20 Biolabs (NASDAQ:AIDX), Can Fite Bi - Benzinga","headline":"12 Health Care Stocks Moving In Wednesday's Pre-Market Session - 20/20 Biolabs (NASDAQ:AIDX), Can Fite Bi","sentiment":"neutral"},{"date":"2026-03-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-03","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPSjZlMHp0UmRWT2FwOGdPZExuaXZVd2tQNVByeEhkNUJHRkRKUmhCQVJ0aEw1eDg1ZUtkekFDR1NZam1UODhNNi1CVlFMSllNNkhsVzNnVVl2QTBFUlZ2cFBSWmVGbHdlcGl3VlRtZG5fZE14LW1jU0pkUjYxTjVDaVl6OTNmbEZnNHFWakVzQ0xmb3l3LWl4eno5VXE3UGgtWVY1Z09jR3NYWHZSQVlRSWk0RGRPQ1ZlUmc?oc=5","date":"2026-02-24","type":"earnings","source":"TradingView","summary":"BrightSpring to Post Q4 Earnings: What's in Store for the Stock? - TradingView","headline":"BrightSpring to Post Q4 Earnings: What's in Store for the Stock?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOMUtLNzBfeHhyaGhPcG9LaWx6UWs2M3FDWW1HYmNEN1dkVE9ZRHhCUmM3NzM4MWNSMFNpckRNMWw0WS13Rk12YUxTVXR2cnZkcDN1SlVuSzY1aFR0LW80QU5FaUx2SFNWWHY2Zmh6NXpOZ2VTdFBGLXRoTXBCM2dqNHY3cnhWQjBIVG1UaGYzU3d2TDJHbTNqMjdCamFmYUpqUTdRQl9Lb3FuRmZxcEZ4ZzU0TGxLcnpZZzhkSEFOSQ?oc=5","date":"2026-02-23","type":"pipeline","source":"Stock Titan","summary":"Eye lens maker STAAR Surgical sets March 3 call on 2025 results, China recovery - Stock Titan","headline":"Eye lens maker STAAR Surgical sets March 3 call on 2025 results, China recovery","sentiment":"neutral"},{"date":"2026-02-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNVkpZSUpINUZuN3ZkTWQ3OEM3Q3M0ZmJSS1NuNWNWVXpyMUFyNFJtNnFBcGcwNFhWWmRvdzJPOTktSjM4WFpZbE9Oek9JaUV2ZUhVbG9BOG5UOTNUa0pSTExpZkxtcy1uZC1ZOWgyZHAtN1lZLS1zWGNwVGdJd3VMMWNKb3pua243dzFValBCZ1llczlpTkxtTm9IMXVLSWFJLVBEQzRNYmxvdmROTTNndUlKcmY?oc=5","date":"2026-01-16","type":"pipeline","source":"Kalkine Media","summary":"STAAR Surgical Company (NASDAQ:STAA) Nasdaq Composite Vision Innovation - Kalkine Media","headline":"STAAR Surgical Company (NASDAQ:STAA) Nasdaq Composite Vision Innovation","sentiment":"neutral"},{"date":"2026-01-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPOGMtQ0U4NXBHalViSkhwV3ZQdmFWUEhSQXJDdkktcU1DcXhsUUx2NzlIcUtmRHdaSE1aUWZyRU9ZeExRaEpjcmQ1OVZsZU8wS3VEV0pGOE9aUzl5NFJXTWFfMU0yUzBoNmlVbk02S19jdlVtQ3FRcmxKZHg1b3BXWElFNjJtcnFJLWNzaF9BVkE2RzRZZkZLSjh5Q2lLa2lZQmxVeUZxUjRlZ2lUbjNncGppc2lwTE5GVWNITkdETQ?oc=5","date":"2026-01-06","type":"pipeline","source":"Stock Titan","summary":"STAAR shareholders just rejected a proposed sale of the company to Alcon - Stock Titan","headline":"STAAR shareholders just rejected a proposed sale of the company to Alcon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNYl9IaU5LQWNSSnd6WHlEVjlLVUw2bU9ScGxRbTZDUXhtX2VPZHdhRnBOWU0yY00xMldpS2kwbDN1UDVSRDNEUHNDQS1xb2lKbFE1U3VON3RFa24zZ3VCTExpMTdxcEVOS0s0Zk9uVTE5TDFTVTB4MU15bGpFZlVXUW5iS2RSbnlLUnR4aW9KeFNDM3ZMTk1QdTFFTkQwb3pX?oc=5","date":"2025-12-10","type":"regulatory","source":"Seeking Alpha","summary":"STAAR Surgical: Alcon Raises Its Bid, But Obstacles Remain (NASDAQ:STAA) - Seeking Alpha","headline":"STAAR Surgical: Alcon Raises Its Bid, But Obstacles Remain (NASDAQ:STAA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPYXloSnQ3ZGFFal9tNWpRRGMxbm5oT05RcFpieXVlSy1BTi1MNXhuNnFkUkJnSzA2Mkg2TVNDSWZWQ3hGeTAzTnBHU3ZBb29EYk1rV3lRZDh2c2lSMzV0S3BJSUFNVW52ZUtWV0VoMDhZSW84bjlvODRqdDdOQU9pQ2tQancxNXdJVFBBaWVMcWRtZ3ptcWdxaE01ZDl4U2xVbUdaR0lLRnJhZ1VTODhxVEZJb2JkeENoX1ppRkt4TjhLRXM4blM0?oc=5","date":"2025-12-09","type":"pipeline","source":"Reuters","summary":"Swiss eyecare giant Alcon lifts bid for rival Staar - Reuters","headline":"Swiss eyecare giant Alcon lifts bid for rival Staar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxQczJfTmsydjN5SDluUmo3TTloLXh3bGwwSklGQmI1V2M0b0ktckVFb2VVamRPOHp2Vkxfd3drQkdON0hlSlg4RjJ2WHFIMDJZU3F1Z2ZxX0JQSDVTdklBaWNxSlVfbmR5dWs2eEZrZS1yTDZVU01WR1poN1c5eDdXaGZDdXJBeUUxM0p0SG55OVBCaFFIZ20tdkhWR244UzhLeUVOMmRYc3ZSTEtqV0N1aWFfeFYyUGxJQ1htU3RlR2VxNmVldEtuSXE4d1pMUFNtWGpwTkpWNThWVWM?oc=5","date":"2025-10-22","type":"pipeline","source":"Reuters","summary":"Staar Surgical's top investor calls shareholder meeting to remove directors - Reuters","headline":"Staar Surgical's top investor calls shareholder meeting to remove directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPT2RldGloaU15ZWp1cGRBcU40WlVaRmdPMFV1TVp5eUs3cENBeTdqYXFqMVgycjlxNUZIcVdwRXBCQTQ2OHVOVVBMUFdCS0s5WHU3bktqYlpzZ2lXOTk4R2dMSnJOUi0tVFVzUFFSSDl2bXExc1BuUVNCUHV4ODRpcEQwdTZxNkxuNndEWERNTzY1TE5heVdCaGQ3Z2owNG9NRGhZ?oc=5","date":"2025-08-05","type":"pipeline","source":"Seeking Alpha","summary":"STAAR Surgical: Takeover Offer Comes At A Significant Premium (NASDAQ:STAA) - Seeking Alpha","headline":"STAAR Surgical: Takeover Offer Comes At A Significant Premium (NASDAQ:STAA)","sentiment":"neutral"}],"patents":[{"drugName":"Visian Toric Implantable Collamer Lens","drugSlug":"visian-toric","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Alcon","Johnson & Johnson","Abbott Laboratories"],"therapeuticFocus":["Ophthalmology"],"financials":{"source":"sec_edgar+yahoo","revenue":239442000,"revenuePeriod":"2026-01-02","revenueHistory":[{"value":239442000,"period":"2026-01-02"},{"value":313901000,"period":"2024-12-27"},{"value":313901000,"period":"2024-12-27"},{"value":322415000,"period":"2023-12-29"},{"value":322415000,"period":"2023-12-29"}],"grossProfit":182420000,"grossProfitHistory":[{"period":"2025-12-31","value":182420000},{"period":"2024-12-31","value":239582000},{"period":"2023-12-31","value":252651000},{"period":"2022-12-31","value":223383000}],"rdSpend":40055000,"rdSpendHistory":[{"period":"2025-12-31","value":40055000},{"period":"2024-12-31","value":45317000},{"period":"2023-12-31","value":40478000},{"period":"2022-12-31","value":35983000}],"sgaSpend":188311000,"operatingIncome":-45946000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-45946000},{"period":"2024-12-31","value":-12611000},{"period":"2023-12-31","value":28097000},{"period":"2022-12-31","value":43802000}],"netIncome":-80448000,"netIncomeHistory":[{"period":"2025-12-31","value":-80448000},{"period":"2024-12-31","value":-20208000},{"period":"2023-12-31","value":21347000},{"period":"2022-12-31","value":39665000}],"eps":-1.62,"epsHistory":[{"period":"2025-12-31","value":-1.62},{"period":"2024-12-31","value":-0.41},{"period":"2023-12-31","value":0.43},{"period":"2022-12-31","value":0.79}],"cash":153150000,"cashHistory":[{"period":"2025-12-31","value":153150000},{"period":"2024-12-31","value":144159000},{"period":"2023-12-31","value":183038000},{"period":"2022-12-31","value":86480000}],"totalAssets":451678000,"totalLiabilities":107494000,"totalDebt":38353000,"equity":344184000,"operatingCashflow":-34230000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-34230000},{"period":"2024-12-31","value":15725000},{"period":"2023-12-31","value":14594000},{"period":"2022-12-31","value":35715000}],"capex":-5820000,"capexHistory":[{"period":"2025-12-31","value":-5820000},{"period":"2024-12-31","value":-23394000},{"period":"2023-12-31","value":-18188000},{"period":"2022-12-31","value":-18108000}],"freeCashflow":-40050000,"dividendsPaid":null,"buybacks":-7981000,"employees":921,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":45432000,"ebit":-10935000,"ebitda":-8519000,"period":"2025-12-31","revenue":57801000,"epsBasic":-0.37,"netIncome":-18309000,"rdExpense":9244000,"epsDiluted":-0.37,"grossProfit":43741000,"operatingIncome":-10935000},{"sga":44224000,"ebit":24442000,"ebitda":26442000,"period":"2025-09-30","revenue":94732000,"epsBasic":0.18,"netIncome":8884000,"rdExpense":9209000,"epsDiluted":0.18,"grossProfit":77875000,"operatingIncome":24442000},{"sga":47252000,"ebit":-24716000,"ebitda":-22741000,"period":"2025-06-30","revenue":44320000,"epsBasic":-0.34,"netIncome":-16812000,"rdExpense":10263000,"epsDiluted":-0.34,"grossProfit":32799000,"operatingIncome":-24716000},{"sga":49079000,"ebit":-34737000,"ebitda":-32400000,"period":"2025-03-31","revenue":42589000,"epsBasic":-1.1,"netIncome":-54211000,"rdExpense":13663000,"epsDiluted":-1.1,"grossProfit":28005000,"operatingIncome":-34737000},{"sga":47516000,"ebit":-27910000,"ebitda":-25535000,"period":"2024-12-31","revenue":48950000,"epsBasic":-0.69,"netIncome":-34228000,"rdExpense":12042000,"epsDiluted":-0.69,"grossProfit":31648000,"operatingIncome":-27910000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":32.65,"previousClose":29.4,"fiftyTwoWeekHigh":35.87,"fiftyTwoWeekLow":15.59,"fiftyTwoWeekRange":"15.59 - 35.87","fiftyDayAverage":22.53,"twoHundredDayAverage":23.81,"beta":1.2,"enterpriseValue":1306491776,"forwardPE":35.5,"priceToBook":4.69,"priceToSales":6.79,"enterpriseToRevenue":5.46,"enterpriseToEbitda":-34.91,"pegRatio":0,"ebitda":-37419000,"ebitdaMargin":-15.6,"freeCashflow":14608750,"operatingCashflow":-34230000,"totalDebt":38353000,"debtToEquity":11.1,"currentRatio":4.55,"returnOnAssets":-5.9,"returnOnEquity":-21.7,"analystRating":"","recommendationKey":"none","numberOfAnalysts":9,"targetMeanPrice":21.11,"targetHighPrice":27,"targetLowPrice":16,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":0.7,"institutionHeldPercent":114.1,"sharesOutstanding":49788295,"floatShares":7552180,"sharesShort":6731885,"shortRatio":5.88,"shortPercentOfFloat":13.5,"epsTrailing":-1.62,"epsForward":0.92,"revenuePerShare":4.83,"bookValue":6.97,"officers":[{"age":48,"name":"Mr. Warren  Foust","title":"Interim Co-CEO, President & COO"},{"age":null,"name":"Dr. Magda  Michna Ph.D.","title":"Chief Development Officer"},{"age":68,"name":"Ms. Deborah J. Andrews","title":"Interim Co-CEO & CFO"},{"age":null,"name":"Ms. Connie  Johnson","title":"Director of Investor Relations"},{"age":null,"name":"Ms. Nancy  Sabin","title":"Chief Marketing Officer"},{"age":62,"name":"Dr. Scott D. Barnes M.D.","title":"Chief Medical Officer"}],"industry":"Medical Instruments & Supplies","irWebsite":"http://www.staar.com/html/investor-info.html","website":"https://www.staar.com","phone":"626 303 7902"}}